Rick Pauls
2023
In 2023, Rick Pauls earned a total compensation of $1.2M as President and Chief Executive Officer at DiaMedica Therapeutics, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $239,958 |
|---|---|
| Option Awards | $396,553 |
| Salary | $562,000 |
| Other | $16,650 |
| Total | $1,215,161 |
Pauls received $562K in salary, accounting for 46% of the total pay in 2023.
Pauls also received $240K in non-equity incentive plan, $396.6K in option awards and $16.7K in other compensation.
Rankings
In 2023, Rick Pauls' compensation ranked 1,002nd out of 2,993 executives tracked by ExecPay. In other words, Pauls earned more than 66.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,002 out of 2,993 | 67th |
Division Manufacturing | 596 out of 1,640 | 64th |
Major group Chemicals And Allied Products | 408 out of 909 | 55th |
Industry group Drugs | 397 out of 872 | 55th |
Industry Pharmaceutical Preparations | 270 out of 630 | 57th |
Source: SEC filing on April 4, 2024.
Pauls' colleagues
We found three more compensation records of executives who worked with Rick Pauls at DiaMedica Therapeutics in 2023.
News
DiaMedica Therapeutics CEO Rick Pauls' 2023 pay rises 12% to $1.2M
April 4, 2024
DiaMedica Therapeutics CEO Rick Pauls' 2022 pay slips 5% to $1.1M
April 4, 2023
DiaMedica Therapeutics CEO Rick Pauls' 2021 pay jumps 29% to $1.1M
April 5, 2022
DiaMedica Therapeutics CEO Rick Pauls' 2019 pay jumps 105% to $1.5M
April 20, 2020
DiaMedica Therapeutics CEO Rick Pauls' 2018 pay jumps 46% to $734K
April 8, 2019